in dermatology

bioXXmed invests in biomedical projects with high diagnostic or therapeutic value. The current focus of investment activity is dermatology.

Too many primary and secondary skin diseases are still insufficiently treatable or incurable. Due to the long-standing commitment to the investment DermaTools Biotech GmbH, the current focus of bioXXmed AG's investments is on the treatment of difficult-to-heal wounds, both chronic and acute. This medical field offers profitable investment opportunities. Numerous other chronic skin conditions with insufficient therapeutic standards also offer room for innovation and are of economic interest.

Investment decisions of

bioXXmed AG requires


bioXXmed AG
Riedstrasse 2
64295 Darmstadt